ACTRN12624000031561已完成1 期
A Phase 1b, Single-centre, Open-label Study to Evaluate Food Effect and the Drug-Drug Interaction of Omeprazole, Itraconazole and Rifampin on Tinlarebant in Healthy Adult Subjects
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- RBP4 Pty Ltd
- 入组人数
- 49
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Healthy male or female, aged between 18 to 65 years of age, inclusive, at screening.
排除标准
- •History of any clinically significant disorder, including cardiovascular (including unstable angina, myocardial infarction, chronic heart failure), haematologic, pulmonary, hepatic, renal, gastrointestinal, connective tissue disease, uncontrolled endocrine/metabolic, oncologic (within the last 5 years), neurologic (including seizures, strokes, brain tumours), and psychiatric diseases, or any disorder that the PI (or delegate) considers may prevent the successful completion of the study or influence the absorption, distribution, metabolism, excretion, or action of the study drug.
研究者
相似试验
进行中（未招募）
1 期
This is a multicenter study that will evaluate the combination of Ripretinib with Binimetinib in Patients with Gastrointestinal Stromal Tumor (GIST)Gastrointestinal Stromal Tumor (GIST)EUCTR2021-000177-80-ESDeciphera Pharmaceuticals, LLC93
进行中（未招募）
不适用
A Phase IV, Single-centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2009/2010 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged = 18 to < 60 years) and ‘Older Adults’ (aged = 60 years)Prophylaxis of influenzaMedDRA version: 9.1Level: LLTClassification code 10022000Term: InfluenzaEUCTR2009-011450-18-GBCSL Limited
进行中（未招募）
不适用
A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2010/2011 Formulation of the Enzira® vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged 18 to 59 years) and ‘Older Adults’ (aged 60 years or older).EUCTR2010-019532-12-GBCSL Limited
进行中（未招募）
不适用
A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® vaccine in Healthy VolunteersInfluenza, humanEUCTR2012-001101-24-GBCSL Limited120
进行中（未招募）
不适用
A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine containing the 2013/2014 Formulation of Enzira® vaccine in Healthy VolunteersInfluenza, humanEUCTR2013-001420-19-GBbioCSL Pty Ltd